DC Circ. Sides With DEA On Marijuana Classification

Law360, Los Angeles (January 22, 2013, 7:53 PM EST) -- A federal appeals court Tuesday upheld the Drug Enforcement Administration’s decision to maintain marijuana as a Schedule I drug, saying medical marijuana advocacy groups failed to provide Food and Drug Administration-approved clinical trials that show acceptable medical uses for the drug.

Medical marijuana advocates, including Americans for Safe Access, the Coalition to Reschedule Cannabis, Patients out of Time and several individuals, had challenged the DEA’s July 2011 denial of a petition that would reschedule marijuana as a schedule III, IV, or V drug because its Schedule...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.